Addison’s Disease Therapeutics Market Share 2022: Global Trends, Key Players, Industry Analysis Report to 2028

The Addison’s Disease Therapeutics Market size is expected to grow at an annual average CAGR of 4% during 2022-2028. Addison’s disease, more commonly known as adrenal insufficiency, is a rare hormonal disorder in which the adrenal glands produce less the hormones cortisol and aldosterone compared to their required amounts. The disease is very life threatening and is prevalent in both men and women of all ages. Some symptoms associated with the disease include extreme fatigue, weight loss, salt cravings, abdominal pain, and nausea. If not diagnosed in the pilot stage, Addison’s disease can lead to the more life-threatening Addison’s crisis. Crisis-related symptoms include hyperpigmentation, dizziness, and severe stomach problems. As mentioned above, Addison’s disease is caused by severe damage to the adrenal glands. The gland is made up of an inner layer and an outer layer capable of producing corticosteroids and aldosterone, respectively.

The following segmentation are covered in this report:

By Diagnosis

• Laboratory Testing
• Imaging Testing

By Drug Class

• Glucocorticoid
• Mineralocorticoid
• Others

By Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Company Profile

• Bristol-Myers Squibb
• Merck
• Novartis
• Pfizer
• Takeda Pharmaceutical
• Bio-Techne
• GlaxoSmithKline
• Lupin Pharmaceuticals
• Abbott
• Amgen
• Bayer
• Biogen
• Eli Lilly and Company
• Boehringer Ingelheim International

Scope of the report

The research study analyses the Addison’s Disease Therapeutics Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Addison’s Disease Therapeutics Market Report

• What was the Addison’s Disease Therapeutics Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028)
• What will be the CAGR of Market during the forecast period (2022-2028)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
• Which manufacturer/vendor/players in the Addison’s Disease Therapeutics Market was the market leader in 2022?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.